# clm_5FB739309DAD

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: total_equity  
value: 10,070,100,000 United States dollar  
valid_from: 2022-09-30  
valid_to: 2022-12-31  
published: 2022-11-01  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_F3CEC0454BF6  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company total equity: 10,070,100,000 United States dollar", as of 2022-09-30 (until 2022-12-31). Claim clm_5FB739309DAD, https://asof.is/claim/clm_5FB739309DAD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947822000250/0000059478-22-000250-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2022, filed 2022-11-01  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947822000250/0000059478-22-000250-index.htm (primary, SEC EDGAR 10-Q Q3 FY2022, published 2022-11-01)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | total_equity | 8,544,700,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_5FB739309DAD](/claim/clm_5FB739309DAD.md) | [clm_B8A59362EB8C](/claim/clm_B8A59362EB8C.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.